Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AVDL
#1626
Avadel Pharmaceuticals plc
21.640
0
+0.05%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.05%
Monthly Change
+0.70%
6 month change
+16.66%
Year Change
+16.66%
Previous Close
21.630
0
Open
21.640
0
Bid
Ask
Low
21.640
0
High
21.640
0
Volume
1 054
Markets
US Stock Market
Healthcare
AVDL
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
58.47 M
59.03 M
64.48 M
90.58 M
96.63 M
—
Valuation ratios
Enterprise value
—
—
—
—
964.2 M
3.87 B
Price to earnings ratio
—
—
—
—
-20.61
1 033.78
Price to sales ratio
—
—
—
—
5.91
19.71
Price to cash flow ratio
—
—
—
—
21.32
380.06
Price to book ratio
—
—
—
—
13.54
23.3
Enterprise value to EBITDA ratio
—
—
—
—
-22.81
—
Profitability ratios
Return on assets %
0.02
-0.31
-1.04
-0.97
-0.3
-0.11
Return on equity %
0.04
-0.99
-6.5
-1.83
-0.66
-0.24
Return on invested capital %
-18.66
-138.33
-237.71
-1 055.02
-455.01
-52.75
Gross margin %
74.29
—
—
96.97
90.97
375.8
Operating margin %
26.04
—
—
-492.97
-25.07
-13.27
EBITDA margin %
275.6
—
—
-482.06
-24.99
—
Net margin %
31.47
—
—
-573.17
-28.87
-32.31
Liquidity ratios
Quick ratio
17.44
—
—
3.36
2.33
9.42
Current ratio
17.44
9.17
1.81
3.64
2.75
11.03
Inventory turnover
3.22
—
—
0.16
1
0.65
Asset turnover
0.1
0
0
0.19
1.03
1.41
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.41
0.58
0.69
0
—
—
Long term debt to total equity ratio
0.79
1.82
4.33
0
—
—
Per share metrics
Operating cash flow per share
-0.89
-1.32
-1.17
-1.6
-0.49
0.35
EBIT per share
0.99
-0.17
—
-1.72
-0.45
0.04
EBITDA per share
1.12
-0.14
—
-1.68
-0.44
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.33
0.87
1.61
1.31
0.78
3.21
Net current asset value per share
4.8
3.29
1.68
1.67
1.41
6.19
Tangible book value per share
2.65
1.05
0.07
0.88
0.6
2.75
Working capital per share
4.52
2.93
0.75
1.21
0.9
3.94
Book value per share
2.95
1.34
0.35
1.09
0.78
3.44
News
Alkermes earnings up next as sleep strategy takes shape
Harmony Biosciences Makes The Grade (NASDAQ:HRMY)
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal
BlackRock discloses 6.94% stake in Avadel Pharmaceuticals
TIG Advisors discloses 4.18% stake in Avadel Pharmaceuticals
Goldman Sachs discloses trading position in Avadel Pharmaceuticals
Janus Henderson discloses 1.87% stake in Avadel Pharmaceuticals
Bank of America discloses 1.3% stake in Avadel Pharmaceuticals
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares
BlackRock discloses 6.92% stake in Avadel Pharmaceuticals
UBS O’Connor discloses 1.1% stake in Avadel Pharmaceuticals
Bank of America discloses 1.32% stake in Avadel Pharmaceuticals